Exact Sciences Corp (EXAS) - Medical Equipment - Deals and Alliances Profile

Exact Sciences Corp (EXAS) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME56354D
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company's flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp (EXAS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Exact Sciences Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Exact Sciences Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Exact Sciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Exact Sciences Corp, Medical Equipment, Deal Details 11

Asset Purchase 11

Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 11

Venture Financing 12

Armune BioScience Raises USD0.5 Million in Venture Financing 12

Armune BioScience Raises USD5 Million in Series A Venture Financing 13

Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 14

Armune BioScience to Raise USD25 Million in Series B Financing 15

Armune BioScience Raises Additional USD5.6 Million in Venture Financing 16

Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 17

Armune BioScience Raises USD3.5 Million in Venture Financing 18

Armune BioScience Raises USD 1.4 Million In Venture Financing 19

Partnerships 20

Exact Sciences and Pfizer Enter into Co-Promotion Agreement 20

MDxHealth Enters into Agreement with Exact Sciences 21

Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 22

Equity Offering 23

Exact Sciences Raises USD245 Million in Public Offering of Shares 23

Exact Sciences Prices Public Offering of Shares for USD132 Million 25

Exact Sciences Prices Public Offering of Shares for USD178.5 Million 26

Exact Sciences Prices Public Offering of Shares for USD103 Million 27

Exact Sciences Completes Public Offering Of Shares For USD 146.6 Million 28

Exact Sciences Completes Public Offering Of Shares For USD 78 Million 30

Exact Sciences Completes Public Offering of Common Stock For USD 62 Million 31

Debt Offering 32

Exact Sciences Prices Public Offering of 1% Convertible Senior Notes Due 2025 for USD190 Million 32

Exact Sciences Raises USD690 Million in Public Offering of Senior Notes Due 2025 33

Acquisition 34

Exact Sciences Acquires Armune Bioscience 34

Exact Sciences Corp-Key Competitors 35

Exact Sciences Corp-Key Employees 36

Exact Sciences Corp-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 39

Strategy And Business Planning 39

Aug 14, 2018: University Research Park Breaks Ground on Corporate Headquarters Building for Exact Sciences 39

Financial Announcements 40

Jan 07, 2018: Exact Sciences to report USD 265.5-266.5 million in revenue, 168 percent growth for 2017 40

Jul 25, 2017: Cologuard revenue increased to USD 57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 41

Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017 42

Other Significant Developments 43

Aug 23, 2018: Exact Sciences and Pfizer to co-market colorectal cancer diagnosis test 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Exact Sciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Exact Sciences Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Exact Sciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Exact Sciences Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Exact Sciences Corp, Medical Equipment, Key Facts, 2017 2

Exact Sciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Exact Sciences Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Exact Sciences Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Exact Sciences Corp, Deals By Market, 2012 to YTD 2018 9

Exact Sciences Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 11

Armune BioScience Raises USD0.5 Million in Venture Financing 12

Armune BioScience Raises USD5 Million in Series A Venture Financing 13

Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 14

Armune BioScience to Raise USD25 Million in Series B Financing 15

Armune BioScience Raises Additional USD5.6 Million in Venture Financing 16

Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 17

Armune BioScience Raises USD3.5 Million in Venture Financing 18

Armune BioScience Raises USD 1.4 Million In Venture Financing 19

Exact Sciences and Pfizer Enter into Co-Promotion Agreement 20

MDxHealth Enters into Agreement with Exact Sciences 21

Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 22

Exact Sciences Raises USD245 Million in Public Offering of Shares 23

Exact Sciences Prices Public Offering of Shares for USD132 Million 25

Exact Sciences Prices Public Offering of Shares for USD178.5 Million 26

Exact Sciences Prices Public Offering of Shares for USD103 Million 27

Exact Sciences Completes Public Offering Of Shares For USD 146.6 Million 28

Exact Sciences Completes Public Offering Of Shares For USD 78 Million 30

Exact Sciences Completes Public Offering of Common Stock For USD 62 Million 31

Exact Sciences Prices Public Offering of 1% Convertible Senior Notes Due 2025 for USD190 Million 32

Exact Sciences Raises USD690 Million in Public Offering of Senior Notes Due 2025 33

Exact Sciences Acquires Armune Bioscience 34

Exact Sciences Corp, Key Competitors 35

Exact Sciences Corp, Key Employees 36

Exact Sciences Corp, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Exact Sciences Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17745
Site License
USD 500 INR 35490
Corporate User License
USD 750 INR 53235

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com